DIO2 catalyzes T4–T3 to activate TH signaling and promote tumor growth, acting through increasing vascular density, regulating the immune microenvironment, and the TGF‐β/EMT/Wnt pathway; overexpression is associated with low promoter methylation. This evidence concerns the gene TGFB1 and neoplasm.